<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(1)</volume><submitter>Levy B</submitter><funding>PHRC</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Reliable predictors of outcomes in venoarterial extracorporeal membrane oxygenation (VA-ECMO) therapy are limited. While elevated lactate levels over time have been linked to outcomes in cardiogenic shock (CS), their significance in VA-ECMO-treated patients remains inconclusive.&lt;h4>Methods&lt;/h4>We conducted a post hoc analysis of data from the HYPO-ECMO trial, which compared normothermia to moderate hypothermia in CS patients supported by VA-ECMO. We examined daily lactate levels collected over a week to assess their correlation with 30-day mortality.&lt;h4>Results&lt;/h4>Among the 318 out of 334 patients (95%) with baseline lactate measurements, 66 had normal levels (&lt; 2.2 mmol/l, 21%). No difference was found in lactate course between moderate hypothermia and normothermia gro</pubmed_abstract><journal>Annals of intensive care</journal><pagination>43</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10973308</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Serial daily lactate levels association with 30-day outcome in cardiogenic shock patients treated with VA-ECMO: a post-hoc analysis of the HYPO-ECMO study.</pubmed_title><pmcid>PMC10973308</pmcid><pubmed_authors>Duarte K</pubmed_authors><pubmed_authors>Bakker J</pubmed_authors><pubmed_authors>Levy B</pubmed_authors><pubmed_authors>Kimmoun A</pubmed_authors><pubmed_authors>Cuau S</pubmed_authors><pubmed_authors>Girerd N</pubmed_authors><pubmed_authors>Baudry G</pubmed_authors><pubmed_authors>HYPO-ECMO trial group and the International ECMO Network (ECMONet)</pubmed_authors></additional><is_claimable>false</is_claimable><name>Serial daily lactate levels association with 30-day outcome in cardiogenic shock patients treated with VA-ECMO: a post-hoc analysis of the HYPO-ECMO study.</name><description>&lt;h4>Background&lt;/h4>Reliable predictors of outcomes in venoarterial extracorporeal membrane oxygenation (VA-ECMO) therapy are limited. While elevated lactate levels over time have been linked to outcomes in cardiogenic shock (CS), their significance in VA-ECMO-treated patients remains inconclusive.&lt;h4>Methods&lt;/h4>We conducted a post hoc analysis of data from the HYPO-ECMO trial, which compared normothermia to moderate hypothermia in CS patients supported by VA-ECMO. We examined daily lactate levels collected over a week to assess their correlation with 30-day mortality.&lt;h4>Results&lt;/h4>Among the 318 out of 334 patients (95%) with baseline lactate measurements, 66 had normal levels (&lt; 2.2 mmol/l, 21%). No difference was found in lactate course between moderate hypothermia and normothermia gro</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-07-15T14:04:02.363Z</modification><creation>2025-04-05T23:16:39.898Z</creation></dates><accession>S-EPMC10973308</accession><cross_references><pubmed>38536534</pubmed><doi>10.1186/s13613-024-01266-6</doi></cross_references></HashMap>